Skip to content

Cervical Cancer Health Center

Medical Reference Related to Cervical Cancer

  1. Changes to This Summary (06 / 14 / 2013)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. General Information About Endometrial CancerRevised text to state that cancer of the endometrium is the most common gynecologic malignancy in the United States, and irregular vaginal bleeding is an early sign and foremost symptom of the highly curable endometrial tumor.Revised text to state that although the collection of cytology specimen is still suggested, a positive result does not upstage the disease. Stage Information for Endometrial CancerAdded text to state that Féderation Internationale de Gynécologie et d'Obstétrique stages are further subdivided by the histologic grade of the tumor, for example, stage IC G2.Treatment Option OverviewAdded text to state that the results of a study by the Danish Endometrial Cancer Group also suggest that the absence of radiation does not improve the

  2. Treatment Options for Recurrent Cervical Cancer

    Treatment of recurrent cervical cancer may include the following:Pelvic exenteration followed by radiation therapy combined with chemotherapy.Chemotherapy as palliative therapy to relieve symptoms caused by the cancer and improve quality of life.Clinical trials of new anticancer drugs or drug combinations.Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent cervical cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

  3. To Learn More About Cervical Cancer

    For more information from the National Cancer Institute about cervical cancer, see the following: Cervical Cancer Home PageWhat You Need to Know About™ Cancer of the CervixCervical Cancer PreventionCervical Cancer ScreeningUnusual Cancers of ChildhoodDrugs Approved to Treat Cervical CancerCryosurgery in Cancer Treatment: Questions and AnswersLasers in Cancer TreatmentUnderstanding Cervical Changes: A Health Guide for WomenHuman Papillomavirus (HPV) VaccinesPap and HPV TestingFor general cancer information and other resources from the National Cancer Institute, see the following:What You Need to Know About™ CancerUnderstanding Cancer Series: CancerCancer StagingChemotherapy and You: Support for People With CancerRadiation Therapy and You: Support for People With CancerCoping with Cancer: Supportive and Palliative CareQuestions to Ask Your Doctor About CancerCancer LibraryInformation For Survivors/Caregivers/Advocates

  4. Recurrent Cervical Cancer

    Recurrent cervical cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back in the cervix or in other parts of the body.

  5. Stage IVB Cervical Cancer

    No standard chemotherapy treatment that provides substantial palliation is available for patients with stage IVB cervical cancer. These patients are appropriate candidates for clinical trials testing single agents or combination chemotherapy employing agents listed below or new anticancer treatments in phase I and II clinical trials.[1]Standard treatment options:Radiation therapy may be used to palliate central disease or distant metastases. Chemotherapy. Tested drugs include the following:Cisplatin (15%–25% response rate).[1,2]Ifosfamide (31% response rate).[3]Paclitaxel (17% response rate).[4,5,6]Ifosfamide-cisplatin.[7,8]Irinotecan (21% response rate in patients previously treated with chemotherapy).[9]Paclitaxel/cisplatin (46% response rate).[10]Cisplatin/gemcitabine (41% response rate).[11]Cisplatin/topotecan (27% response rate).[12]Treatment options under clinical evaluation:New anticancer drugs in phase I and phase II clinical trials.Information about ongoing clinical trials

  6. Cellular Classification of Endometrial Cancer

    The most common endometrial cancer cell type is endometrioid adenocarcinoma, which is composed of malignant glandular epithelial elements; an admixture of squamous metaplasia is not uncommon. Adenosquamous tumors contain malignant elements of both glandular and squamous epithelium;[1] clear cell and papillary serous carcinoma of the endometrium are tumors that are histologically similar to those noted in the ovary and the fallopian tube, and the prognosis is worse for these tumors.[2] Mucinous, squamous, and undifferentiated tumors are rarely encountered. Frequency of endometrial cancer cell types is as follows: Endometrioid (75%–80%). Ciliated adenocarcinoma.Secretory adenocarcinoma.Papillary or villoglandular.Adenocarcinoma with squamous differentiation.Adenoacanthoma.Adenosquamous.Uterine papillary serous (<10%).Mucinous (1%).Clear cell (4%).Squamous cell (<1%).Mixed (10%).Undifferentiated.References: Zaino RJ, Kurman R, Herbold D, et al.: The significance of squamous

  7. Recurrent Uterine Sarcoma

    There is currently no standard therapy for patients with recurrent disease. These patients should be entered into an ongoing clinical trial. Patients who present with uterine sarcoma have been treated on a series of phase II studies by the Gynecologic Oncology Group, including the GOG-87B trial, for example. These chemotherapy studies have documented some antitumor activity for cisplatin, doxorubicin, and ifosfamide. These studies have also documented differences in response leading to separate trials for patients with carcinosarcomas and leiomyosarcomas. As an example, in patients previously untreated with chemotherapy, ifosfamide had a 32.2% response rate in patients with carcinosarcomas,[1] a 33% response rate in patients with endometrial stromal cell sarcomas,[2] and a 17.2% partial response rate in patients with leiomyosarcomas.[3] Doxorubicin in combination with dacarbazine or cyclophosphamide is no more active than doxorubicin alone for recurrent disease.[4,5] Cisplatin has

  8. nci_ncicdr0000062759-nci-header

    This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Cervical Cancer Treatment

  9. General Information About Cervical Cancer

    WebMD explains the types of cervical cancer and the prognosis when you're diagnosed in different stages.

  10. Get More Information From NCI

    Call 1-800-4-CANCERFor more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions.Chat online The NCI's LiveHelp® online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer. Write to usFor more information from the NCI, please write to this address:NCI Public Inquiries Office9609 Medical Center Dr. Room 2E532 MSC 9760Bethesda, MD 20892-9760Search the NCI Web siteThe NCI Web site provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support

Displaying 21 - 30 of 170 Articles << Prev Page 1 2 3 4 5 6 7 8 9 10 Next >>

Today on WebMD

cancer cell
HPV is the top cause. Find out more.
doctor and patient
Get to know the Symptoms.
 
sauteed cherry tomatoes
Fight cancer one plate at a time.
Lung cancer xray
See it in pictures, plus read the facts.
 
Integrative Medicine Cancer Quiz
QUIZ
Lifestyle Tips for Depression Slideshow
SLIDESHOW
 
Screening Tests for Women
Slideshow
what is your cancer risk
HEALTH CHECK